Bill Mc Elroy
About Bill Mc Elroy
Bill Mc Elroy is the Director of Medicinal Chemistry at Alkermes in Waltham, MA, with extensive experience in hit finding, high throughput screens, and identifying novel targets.
Company
Bill McElroy is currently serving as Director of Medicinal Chemistry at Alkermes in Waltham, MA. Alkermes is a biopharmaceutical company that focuses on central nervous system and oncology. As part of his role, McElroy is likely responsible for leading teams and projects aimed at discovering and developing small molecules for therapeutic use.
Title
Bill McElroy holds the title of Director, Medicinal Chemistry at Alkermes. His role involves overseeing medicinal chemistry efforts, including hit finding, high throughput screens, and the development of advanced bioavailable leads for efficacy studies. His work aims at contributing to the discovery of new therapeutic agents.
Education and Expertise
Bill McElroy holds a PhD in Chemistry from the University of Maryland. He also has a Bachelor of Science in Chemistry with a Minor in Mathematics from Muhlenberg College. McElroy has deep expertise in hit finding, high throughput screens, and identifying novel targets, including previously 'undruggable' proteins and pathways. His extensive background in medicinal chemistry includes leading teams to identify chemical probes, Protacs, in vivo tools, and advanced bioavailable leads for efficacy studies.
Professional Background
Bill McElroy's professional timeline showcases his expertise in medicinal chemistry. He worked as a Postdoc at The University of Texas at Austin from 2005 to 2007. Following this, he joined Schering-Plough Research Institute as Senior Scientist, Medicinal Chemistry, where he worked until 2009. He then spent a decade at Merck as Associate Principal Scientist, Chemical Biology. In 2019, he became Principal Scientist, Medicinal Chemistry at Kintai Therapeutics, and in 2020 held the same title at Constellation Pharmaceuticals. Since 2021, he has been with Alkermes as Director, Medicinal Chemistry.
Achievements
Bill McElroy has led teams responsible for identifying chemical probes, Protacs, in vivo tools, and advanced bioavailable leads for efficacy studies. His contributions to the field are documented in a full list of peer-reviewed publications available on ResearchGate. His work includes high throughput screens and identifying novel targets, significantly contributing to the advancements in medicinal chemistry.